pmc-enju-pas Home  

PMC:3279418 / 12940-13284 JSONTXT 6 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4926 0-5 EX denotes There
T4927 6-9 VB denotes are
T4928 10-11 DT denotes a
T4929 12-18 NN denotes number
T4930 19-21 IN denotes of
T4931 22-30 JJ denotes possible
T4932 31-43 NN denotes explanations
T4933 44-47 IN denotes for
T4934 48-51 DT denotes the
T4935 52-61 JJ denotes defective
T4936 62-70 NN denotes cytokine
T4937 71-80 NN denotes secretion
T4938 81-83 IN denotes in
T4939 84-94 VB denotes stimulated
T4940 95-99 NN denotes cpdm
T4941 100-104 NN denotes BMDC
T4942 104-105 -COMMA- denotes ,
T4943 106-115 VB denotes including
T4944 116-117 CD denotes 1
T4945 117-118 -RRB- denotes )
T4946 119-126 VB denotes reduced
T4947 127-134 NN denotes surface
T4948 135-145 NN denotes expression
T4949 146-148 IN denotes of
T4950 149-152 DT denotes the
T4951 153-156 NN denotes LPS
T4952 157-165 NN denotes receptor
T4953 166-173 NN denotes complex
T4954 173-174 -COMMA- denotes ,
T4955 175-176 CD denotes 2
T4956 176-177 -RRB- denotes )
T4957 178-187 VB denotes increased
T4958 188-198 NN denotes production
T4959 199-201 IN denotes of
T4960 202-219 JJ denotes anti-inflammatory
T4961 220-229 NN denotes mediators
T4962 229-230 -COMMA- denotes ,
T4963 231-232 CD denotes 3
T4964 232-233 -RRB- denotes )
T4965 234-243 VB denotes increased
T4966 244-254 NN denotes expression
T4967 255-257 IN denotes of
T4968 258-266 JJ denotes negative
T4969 267-277 NN denotes regulators
T4970 278-280 IN denotes of
T4971 281-284 NN denotes TLR
T4972 285-293 NN denotes pathways
T4973 293-294 -COMMA- denotes ,
T4974 295-298 CC denotes and
T4975 299-300 CD denotes 4
T4976 300-301 -RRB- denotes )
T4977 302-310 JJ denotes impaired
T4978 311-322 JJ denotes TLR-induced
T4979 323-332 NN denotes signaling
T4980 333-343 NN denotes activation
R4061 T4926 T4927 arg1Of There,are
R4062 T4929 T4927 arg2Of number,are
R4063 T4929 T4928 arg1Of number,a
R4064 T4929 T4930 arg1Of number,of
R4065 T4929 T4933 arg1Of number,for
R4066 T4932 T4930 arg2Of explanations,of
R4067 T4932 T4931 arg1Of explanations,possible
R4068 T4937 T4935 arg1Of secretion,defective
R4069 T4937 T4936 arg1Of secretion,cytokine
R4070 T4937 T4938 arg1Of secretion,in
R4071 T4937 T4942 arg1Of secretion,","
R4072 T4937 T4943 arg1Of secretion,including
R4073 T4937 T4956 arg1Of secretion,)
R4074 T4937 T4965 modOf secretion,increased
R4075 T4937 T4974 arg1Of secretion,and
R4076 T4941 T4938 arg2Of BMDC,in
R4077 T4941 T4939 arg2Of BMDC,stimulated
R4078 T4941 T4940 arg1Of BMDC,cpdm
R4079 T4948 T4943 arg2Of expression,including
R4080 T4948 T4944 arg1Of expression,1
R4081 T4948 T4945 arg1Of expression,)
R4082 T4948 T4946 arg2Of expression,reduced
R4083 T4948 T4947 arg1Of expression,surface
R4084 T4948 T4949 arg1Of expression,of
R4085 T4953 T4949 arg2Of complex,of
R4086 T4953 T4950 arg1Of complex,the
R4087 T4953 T4951 arg1Of complex,LPS
R4088 T4953 T4952 arg1Of complex,receptor
R4089 T4953 T4954 arg1Of complex,","
R4090 T4955 T4954 arg2Of 2,","
R4091 T4958 T4957 arg2Of production,increased
R4092 T4958 T4959 arg1Of production,of
R4093 T4958 T4965 arg1Of production,increased
R4094 T4961 T4959 arg2Of mediators,of
R4095 T4961 T4960 arg1Of mediators,anti-inflammatory
R4096 T4961 T4962 arg1Of mediators,","
R4097 T4961 T4964 arg1Of mediators,)
R4098 T4963 T4962 arg2Of 3,","
R4099 T4966 T4965 arg2Of expression,increased
R4100 T4966 T4967 arg1Of expression,of
R4101 T4969 T4967 arg2Of regulators,of
R4102 T4969 T4968 arg1Of regulators,negative
R4103 T4969 T4970 arg1Of regulators,of
R4104 T4972 T4970 arg2Of pathways,of
R4105 T4972 T4971 arg1Of pathways,TLR
R4106 T4974 T4933 arg2Of and,for
R4107 T4974 T4934 arg1Of and,the
R4108 T4974 T4973 arg1Of and,","
R4109 T4980 T4974 arg2Of activation,and
R4110 T4980 T4975 arg1Of activation,4
R4111 T4980 T4976 arg1Of activation,)
R4112 T4980 T4977 arg1Of activation,impaired
R4113 T4980 T4978 arg1Of activation,TLR-induced
R4114 T4980 T4979 arg1Of activation,signaling